Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Oncogene ; 25(31): 4310-9, 2006 Jul 20.
Artigo em Inglês | MEDLINE | ID: mdl-16501597

RESUMO

Here, we show that ectopic expression of the catalytic subunit of mouse telomerase (mTert) confers a growth advantage to primary murine embryonic fibroblasts (MEFs), which have very long telomeres, as well as facilitates their spontaneous immortalization and increases their colony-forming capacity upon activation of oncogenes. We demonstrate that these telomere length-independent growth-promoting effects of mTert overexpression require catalytically active mTert, as well as the formation of mTert/Terc complexes. The gene expression profile of mTert-overexpressing MEFs indicates that telomerase enhances growth in these cells through the repression of growth-inhibiting genes of the transforming growth factor-beta (TGF-beta) signaling network. We functionally validate this result by showing that mTert abrogates the growth-inhibitory effect of TGF-beta in MEFs, thus demonstrating that telomerase increments the proliferative potential of primary mouse embryonic fibroblasts by targeting the TGF-beta pathway.


Assuntos
Proteínas de Ligação a DNA/biossíntese , Proteínas de Ligação a DNA/genética , Transdução de Sinais/fisiologia , Telomerase/fisiologia , Fator de Crescimento Transformador beta/fisiologia , Animais , Células Cultivadas , Proteínas de Ligação a DNA/deficiência , Proteínas de Ligação a DNA/fisiologia , Perfilação da Expressão Gênica , Inibidores do Crescimento/antagonistas & inibidores , Inibidores do Crescimento/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Retroviridae/genética , Telomerase/biossíntese , Telomerase/deficiência , Telomerase/genética , Transdução Genética , Fator de Crescimento Transformador beta/antagonistas & inibidores
2.
Mol Endocrinol ; 15(10): 1803-16, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11579212

RESUMO

The Pem homeobox transcription factor is expressed under androgen control in the testis and epididymis. It is also transcribed in the ovary, muscle, and placenta. The mouse Pem gene promoter was cloned and sequenced. It was analyzed in transactivation tests using CV-1 and PC-3 cells expressing the AR and found to be strongly stimulated by androgens. EMSAs and mutational analysis of the Pem promoter allowed the identification of two functional androgen response elements named ARE-1 and ARE-2. They both differed from the consensus semipalindromic steroid response element and exhibited characteristics of direct repeats of the TGTTCT half-site. Unlike the steroid response element, both Pem androgen response elements were selectively responsive to androgen stimulation. Specific mutations in the left half-site of Pem ARE-1 and ARE-2, but not of the steroid response element, were still compatible with AR binding in the EMSA. In addition, Pem ARE-1, but not ARE-2 or the steroid response element, showed some flexibility with regard to spacing between half-sites. These results strongly suggest that the AR interacts differently with direct repeats than with inverted repeats, potentially leading to cis element-driven selective properties. Thus, the existence of several classes of DNA response elements might be an essential feature of differential androgen regulation.


Assuntos
Androgênios/farmacologia , Proteínas de Homeodomínio/genética , Regiões Promotoras Genéticas , Elementos de Resposta , Fatores de Transcrição/genética , Ativação Transcricional , Animais , Sequência de Bases , Clonagem Molecular , Sequência Conservada , DNA/química , DNA/metabolismo , Ensaio de Desvio de Mobilidade Eletroforética , Glucocorticoides/farmacologia , Camundongos , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Progestinas/farmacologia , Ratos , Receptores Androgênicos/metabolismo , Alinhamento de Sequência , Relação Estrutura-Atividade , Transfecção
3.
Biotechnol Bioeng ; 69(3): 266-74, 2000 Aug 05.
Artigo em Inglês | MEDLINE | ID: mdl-10861406

RESUMO

A perfused cell-culture process was developed to investigate the stability of IRF-1-mediated proliferation control in BHK cells and to evaluate the efficacy of a novel promoter in these cells. The cell density of proliferation-controlled producer cells was effectively regulated for over 7 weeks in a microcarrier-based continuously perfused bioreactor. An IRF-1-inducible promoter was employed to express a heterodimeric IgG antibody as a relevant model protein. Basal expression levels were equivalent to that of a highly active viral promoter, while productivity increased up to sixfold during growth arrest. However, no stably expressing clone was isolated in this study. Protein expression decreased gradually with time and could not be induced further in subsequent growth-repression cycles. The results demonstrate that the regulatory system is sufficiently stable to allow controlled growth in a continuous scalable reactor system and that productivity increases can be achieved in a proliferation controlled microcarrier culture.


Assuntos
Reatores Biológicos , Divisão Celular , Técnicas de Cultura/métodos , Perfusão , Animais , Contagem de Células , Linhagem Celular , Sobrevivência Celular , Células Clonais/citologia , Células Clonais/efeitos dos fármacos , Células Clonais/metabolismo , Cricetinae , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Dimerização , Estrogênios/farmacologia , Genes Virais/genética , Imunoglobulina G/biossíntese , Imunoglobulina G/genética , Imunoglobulina G/metabolismo , Fator Regulador 1 de Interferon , Microesferas , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Regiões Promotoras Genéticas/genética , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Fatores de Tempo , Ativação Transcricional/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...